Skip to main content
. 2025 Aug 26;16:1647065. doi: 10.3389/fneur.2025.1647065

Table 3.

Independent risk factor analysis for moderate-to-severe Fazekas-scored WMH across subtypes.

Variable PWMH DWMH
β OR(95%CI) p β OR(95%CI) p
Age (per year) 0.088 1.09 (1.07–1.12) <0.0001 0.033 1.034(1.013 ~ 1.056) 0.001
Sex (Male) −0.039 0.96 (0.55–1.67) 0.888 −0.615 0.541(0.287 ~ 0.986) 0.050
Hypertension 1.070 2.92 (1.93–4.43) <0.0001 0.743 2.102(1.341 ~ 3.350) 0.001
Coronary heart disease 0.099 1.10 (0.65–1.89) 0.716 −0.064 0.938(0.552 ~ 1.566) 0.809
Diabetes mellitus 0.138 1.15 (0.76–1.74) 0.513 0.440 1.553(1.022 ~ 2.363) 0.039
Smoking history 0.230 1.26 (0.68–2.33) 0.462 0.685 1.983(1.037 ~ 3.876) 0.041
Alcohol consumption 0.352 1.42 (0.79–2.57) 0.241 0.447 1.564(0.852 ~ 2.895) 0.151
Creatinine abnormality 0.732 2.07 (1.18–3.72) 0.012 0.172 1.188(0.681 ~ 2.042) 0.538
Uric acid abnormality 0.341 1.41 (0.86–2.31) 0.174 0.365 1.440(0.883 ~ 2.329) 0.140
Cys-C abnormality −0.657 0.52 (0.27–0.98) 0.045 −0.067 0.935(0.494 ~ 1.735) 0.833
β2-MG abnormality 0.088 1.09 (1.07–1.12) 0.347 0.579 1.785(1.022 ~ 3.097) 0.040
Hyperlipidemia −0.039 0.96 (0.55–1.67) 0.477 −0.422 0.656(0.430 ~ 0.996) 0.049

Bold values indicate statistically significant results (p < 0.05).